Clinafloxacin Hydrochloride (CAS 105956-99-8) Suppliers and Product Information

Clinafloxacin hydrochloride is a fluoroquinolone antibiotic with broad-spectrum activity against gram-positive and gram-negative bacteria. It inhibits both DNA gyrase and topoisomerase IV. The compound is currently under research and development for the treatment of serious infections.

Clinafloxacin has shown high potency against Streptococcus pneumoniae and other pathogens in vitro. It has been evaluated for both oral and intravenous administration.

Frequently Asked Questions

Q: What is the primary use of clinafloxacin hydrochloride?

A: Clinafloxacin hydrochloride is primarily used as a broad-spectrum antibiotic for treating serious bacterial infections. It is effective against both gram-positive and gram-negative bacteria.

Q: How does clinafloxacin work?

A: Clinafloxacin works by inhibiting two essential bacterial enzymes: DNA gyrase and topoisomerase IV. This dual inhibition mechanism contributes to its broad-spectrum antibacterial activity.

Q: Is clinafloxacin approved for clinical use?

A: As of now, clinafloxacin is still under research and development. Its approval and release have been halted due to concerns about serious side effects, and it is not currently approved for clinical use.